Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-055783

Senior Vice President, Finance sold 22,500 shares at $35.00 ($787,500)

  • Senior Vice President, Finance acquired 22,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-09-13 Option exercise +22,500 $4.12 $92,700 38,077 D: show line 1 in the form
Catinazzo Thomas Senior Vice President, Finance 2021-09-13 Sale −22,500 $35.00 $787,500 15,577 D: show line 2 in the form
Open-market sales · 22,500 sh · avg $35.00 · $787,500

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-09-13 Option exercise · Stock Option (Right to Buy) −22,500 62,043 D: show line 3 in the form
Loading xslF345X03/doc4.xml…